These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 38374141)

  • 21. Broadening horizons in mechanisms, management, and treatment of diabetic kidney disease.
    Petrazzuolo A; Sabiu G; Assi E; Maestroni A; Pastore I; Lunati ME; Montefusco L; Loretelli C; Rossi G; Ben Nasr M; Usuelli V; Xie Y; Balasubramanian HB; Zocchi M; El Essawy B; Yang J; D'Addio F; Fiorina P
    Pharmacol Res; 2023 Apr; 190():106710. PubMed ID: 36871895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SUMO specific peptidase 6 regulates the crosstalk between podocytes and glomerular endothelial cells in diabetic kidney disease.
    Guo F; Song Y; Wu L; Zhao Y; Ma X; Wang J; Shao M; Ji H; Huang F; Fan X; Wang S; Qin G; Yang B
    Biochim Biophys Acta Mol Basis Dis; 2023 Jun; 1869(5):166685. PubMed ID: 36889557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single-Cell RNA Profiling of Glomerular Cells Shows Dynamic Changes in Experimental Diabetic Kidney Disease.
    Fu J; Akat KM; Sun Z; Zhang W; Schlondorff D; Liu Z; Tuschl T; Lee K; He JC
    J Am Soc Nephrol; 2019 Apr; 30(4):533-545. PubMed ID: 30846559
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tongxinluo Inhibits Renal Fibrosis in Diabetic Nephropathy: Involvement of the Suppression of Intercellular Transfer of TGF-[Formula: see text]1-Containing Exosomes from GECs to GMCs.
    Wu XM; Gao YB; Xu LP; Zou DW; Zhu ZY; Wang XL; Yao WJ; Luo LT; Tong Y; Tian NX; Han ZJ; Dang WY
    Am J Chin Med; 2017; 45(5):1075-1092. PubMed ID: 28659030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glomerular podocytes in diabetic renal disease.
    Podgórski P; Konieczny A; Lis Ł; Witkiewicz W; Hruby Z
    Adv Clin Exp Med; 2019 Dec; 28(12):1711-1715. PubMed ID: 31851794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Crosstalk in glomerular injury and repair.
    Dimke H; Maezawa Y; Quaggin SE
    Curr Opin Nephrol Hypertens; 2015 May; 24(3):231-8. PubMed ID: 25887901
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular Mechanisms in Early Diabetic Kidney Disease: Glomerular Endothelial Cell Dysfunction.
    Lassén E; Daehn IS
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33322614
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy.
    Ziyadeh FN; Wolf G
    Curr Diabetes Rev; 2008 Feb; 4(1):39-45. PubMed ID: 18220694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A 3D tri-culture system reveals that activin receptor-like kinase 5 and connective tissue growth factor drive human glomerulosclerosis.
    Waters JP; Richards YC; Skepper JN; Southwood M; Upton PD; Morrell NW; Pober JS; Bradley JR
    J Pathol; 2017 Nov; 243(3):390-400. PubMed ID: 28815607
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glomerular cell death and inflammation with high-protein diet and diabetes.
    Meek RL; LeBoeuf RC; Saha SA; Alpers CE; Hudkins KL; Cooney SK; Anderberg RJ; Tuttle KR
    Nephrol Dial Transplant; 2013 Jul; 28(7):1711-20. PubMed ID: 23314315
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Players: Cells Involved in Glomerular Disease.
    Kitching AR; Hutton HL
    Clin J Am Soc Nephrol; 2016 Sep; 11(9):1664-1674. PubMed ID: 27073196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proteinuria in diabetic kidney disease: a mechanistic viewpoint.
    Jefferson JA; Shankland SJ; Pichler RH
    Kidney Int; 2008 Jul; 74(1):22-36. PubMed ID: 18418356
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppressed ER-associated degradation by intraglomerular cross talk between mesangial cells and podocytes causes podocyte injury in diabetic kidney disease.
    Fujimoto D; Kuwabara T; Hata Y; Umemoto S; Kanki T; Nishiguchi Y; Mizumoto T; Hayata M; Kakizoe Y; Izumi Y; Takahashi S; Mukoyama M
    FASEB J; 2020 Nov; 34(11):15577-15590. PubMed ID: 32996639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Research progress on the role of ET-1 in diabetic kidney disease.
    Zhang S; Li X; Liu S; Zhang W; Li M; Qiao C
    J Cell Physiol; 2023 Jun; 238(6):1183-1192. PubMed ID: 37063089
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The crosstalk between glomerular endothelial cells and podocytes controls their responses to metabolic stimuli in diabetic nephropathy.
    Albrecht M; Sticht C; Wagner T; Hettler SA; De La Torre C; Qiu J; Gretz N; Albrecht T; Yard B; Sleeman JP; Garvalov BK
    Sci Rep; 2023 Oct; 13(1):17985. PubMed ID: 37863933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The CXCR4-AT1 axis plays a vital role in glomerular injury via mediating the crosstalk between podocyte and mesangial cell.
    Wu Q; Zhou S; Xu D; Meng P; Chen Q; Wang X; Li X; Chen S; Ye H; Ye W; Xiong Y; Li J; Miao J; Shen W; Lin X; Hou FF; Liu Y; Zhang Y; Zhou L
    Transl Res; 2024 Feb; 264():15-32. PubMed ID: 37696390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Research progress on multiple cell death pathways of podocytes in diabetic kidney disease.
    Yang C; Zhang Z; Liu J; Chen P; Li J; Shu H; Chu Y; Li L
    Mol Med; 2023 Oct; 29(1):135. PubMed ID: 37828444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transgenic overexpression of GLUT1 in mouse glomeruli produces renal disease resembling diabetic glomerulosclerosis.
    Wang Y; Heilig K; Saunders T; Minto A; Deb DK; Chang A; Brosius F; Monteiro C; Heilig CW
    Am J Physiol Renal Physiol; 2010 Jul; 299(1):F99-F111. PubMed ID: 20375117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tyro3 is a podocyte protective factor in glomerular disease.
    Zhong F; Chen Z; Zhang L; Xie Y; Nair V; Ju W; Kretzler M; Nelson RG; Li Z; Chen H; Wang Y; Zhang A; Lee K; Liu Z; He JC
    JCI Insight; 2018 Nov; 3(22):. PubMed ID: 30429374
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reducing VEGF-B Signaling Ameliorates Renal Lipotoxicity and Protects against Diabetic Kidney Disease.
    Falkevall A; Mehlem A; Palombo I; Heller Sahlgren B; Ebarasi L; He L; Ytterberg AJ; Olauson H; Axelsson J; Sundelin B; Patrakka J; Scotney P; Nash A; Eriksson U
    Cell Metab; 2017 Mar; 25(3):713-726. PubMed ID: 28190774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.